| Product NDC: | 43386-360 |
| Proprietary Name: | Phenelzine Sulfate |
| Non Proprietary Name: | Phenelzine Sulfate |
| Active Ingredient(s): | 15 mg/1 & nbsp; Phenelzine Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43386-360 |
| Labeler Name: | GAVIS Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200181 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101214 |
| Package NDC: | 43386-360-21 |
| Package Description: | 60 TABLET in 1 BOTTLE (43386-360-21) |
| NDC Code | 43386-360-21 |
| Proprietary Name | Phenelzine Sulfate |
| Package Description | 60 TABLET in 1 BOTTLE (43386-360-21) |
| Product NDC | 43386-360 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Phenelzine Sulfate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101214 |
| Marketing Category Name | ANDA |
| Labeler Name | GAVIS Pharmaceuticals, LLC |
| Substance Name | PHENELZINE SULFATE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |